Marking A Year’s Milestones

In 2022, Pfizer continued to strive to enhance shareholder value through development of its innovative R&D pipeline and strategic acquisitions, while maintaining its focus on health equity and environmental stewardship.

As the company looks to build on these initiatives moving forward, here’s a look at some of the key achievements from the past year.